Transmass Tm Biomedical Services India Private Limited

Provides research, development, calibration, manufacturing, servicing, and testing for biomedical and radiology equipment.

2015 | Bangaluru, Karnataka (India) | Active
Last Updated: January 08, 2025

Transmass Tm Biomedical Services India Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 9 Year, 5 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth -99.87%
  • Profit Growth 64.51%
  • Ebitda 76.57%
  • Net Worth -27.50%
  • Total Assets -0.59%

About Transmass Tm Biomedical Services India

Transmass Tm Biomedical Services India Private Limited (TTBSIPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 August 2015 (Nine years and five months 24 days old ). Its registered office is in Bangaluru, Karnataka, India.

The Company is engaged in the Healthcare Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.

Snehashis Chakraborty, Suresh Kumar, and Vijaya Kumar serve as directors at the Company.

Company Details

  • Location

    Bangaluru, Karnataka, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website
  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U93000KA2015PTC082313

  • Company No.

    082313

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    17 Aug 2015

  • Date of AGM

    16 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Bangalore

Industry

Healthcare
Travel and Hospitality

What products or services does Transmass Tm Biomedical Services India Private Limited offer?

Transmass Tm Biomedical Services India Private Limited offers a wide range of products and services, including Material Testing Labs & Services, Testing Services, Medical Test Services, Diagnostic Lab, Computer Hardware & Network Support, Network Maintenance Services, Chemical Testing Services, Chemical Testing Laboratory, Electrical Testing Service.

Who are the key members and board of directors at Transmass Tm Biomedical Services India?

Board Members (3)

Name Designation Appointment Date Status
Suresh Kumar Country flag representing In Director 17-Aug-2015 Current
Snehashis Chakraborty Country flag representing In Director 17-Aug-2015 Current
Vijaya Kumar Country flag representing In Director 14-Jul-2023 Current

Financial Performance of Transmass Tm Biomedical Services India.

Transmass Tm Biomedical Services India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 99.87% decrease. The company also saw a substantial improvement in profitability, with a 64.51% increase in profit. The company's net worth observed a substantial decline by a decrease of 27.5%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
-99.87%
Revenue from Operations
Total Assets
-0.59%
Profit or Loss
64.51%
Net Worth
-27.50%
EBITDA
76.57%

What is the Ownership and Shareholding Structure of Transmass Tm Biomedical Services India?

In 2020, Transmass Tm Biomedical Services India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Transmass Tm Biomedical Services India?

Unlock and access historical data on people associated with Transmass Tm Biomedical Services India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Transmass Tm Biomedical Services India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Transmass Tm Biomedical Services India's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Transmass Tm Biomedical Services India

Recent activity within the organization

  • Annual General Meeting

    Transmass Tm Biomedical Services India Private Limited last Annual general meeting of members was held on 16 Sep 2024 as per latest MCA records.

    16 Sep 2024

  • Balance Sheet

    Transmass Tm Biomedical Services India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.

    31 Mar 2024

  • Director Appointment

    Vijaya Kumar was appointed as a Director was appointed as a Director on 14 Jul 2023 & has been associated with this company since 1 year 6 months .

    14 Jul 2023

  • Director Appointment

    Snehashis Chakraborty was appointed as a Director was appointed as a Director on 17 Aug 2015 & has been associated with this company since 9 years 5 months .

    17 Aug 2015

  • Director Appointment

    Suresh Kumar was appointed as a Director was appointed as a Director on 17 Aug 2015 & has been associated with this company since 9 years 5 months .

    17 Aug 2015

  • Company Incorporation

    Transmass Tm Biomedical Services India Private Limited was registered on 17 Aug 2015 with Roc Bangalore & aged 9 years 5 months as per MCA records.

    17 Aug 2015

Frequently asked questions

  • Transmass Tm Biomedical Services India Private Limited was incorporated on 17 Aug 2015.

  • The authorized share capital of Transmass Tm Biomedical Services India Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.

  • Currently 3 directors are associated with Transmass Tm Biomedical Services India Private Limited.

    • Snehashis Chakraborty
    • Suresh Kumar
    • Vijaya Kumar
  • As per Ministry of Corporate Affairs (Mca), the registered address of Transmass Tm Biomedical Services India Private Limited is No. 96/1-1 (Mezzanine Floor) 9Th Cross East Park Road, Malleswaram India, Bangalore, Karnataka, 560003.

  • The corporate identification number (CIN) of Transmass Tm Biomedical Services India Private Limited is U93000KA2015PTC082313 and the company number is 082313 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Transmass Tm Biomedical Services India Private Limited is https://www.tepl.info

  • According to the financial reports for the fiscal year 2022, the revenue trend for Transmass Tm Biomedical Services India Private Limited has fallen by -99.87%.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Transmass Tm Biomedical Services India Private Limited has experienced an downturn of -27.50%.

  • The most recent Balance Sheet for Transmass Tm Biomedical Services India Private Limited was filed with the ROC on 31 Mar 2024.